Abbott To Wrap Up $25B St. Jude Buy With FTC's Approval
U.S.-based global health care giant Abbott Laboratories is set to close its $25 billion cash-and-stock acquisition of St. Jude Medical Inc. on Wednesday now that it has agreed to divest two...To view the full article, register now.
Already a subscriber? Click here to view full article